Literature DB >> 32360949

Current knowledge on Hepatitis Delta Virus replication.

Julie Lucifora1, Marion Delphin2.   

Abstract

Hepatitis B Virus (HBV) that infects liver parenchymal cells is responsible for severe liver diseases and co-infection with Hepatitis Delta Virus (HDV) leads to the most aggressive form of viral hepatitis. Even tough being different for their viral genome (relaxed circular partially double stranded DNA for HBV and circular RNA for HDV), HBV and HDV are both maintained as episomes in the nucleus of infected cells and use the cellular machinery for the transcription of their viral RNAs. We propose here an update on the current knowledge on HDV replication cycle that may eventually help to identify new antiviral targets.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Episome; Hepatitis B virus (HBV); Hepatitis delta virus (HDV); Hepatocyte; Life cycle

Mesh:

Year:  2020        PMID: 32360949     DOI: 10.1016/j.antiviral.2020.104812

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  8 in total

Review 1.  Virus spread in the liver: mechanisms, commonalities, and unanswered questions.

Authors:  Alexi Tallan; Zongdi Feng
Journal:  Future Virol       Date:  2020-10-27       Impact factor: 1.831

2.  Hepatitis Delta Virus Genome RNA Synthesis Initiates at Position 1646 with a Nontemplated Guanosine.

Authors:  Susannah Stephenson-Tsoris; John L Casey
Journal:  J Virol       Date:  2021-12-08       Impact factor: 6.549

Review 3.  Interplay between Hepatitis D Virus and the Interferon Response.

Authors:  Zhenfeng Zhang; Stephan Urban
Journal:  Viruses       Date:  2020-11-20       Impact factor: 5.048

4.  Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus Infections.

Authors:  Julie Lucifora; Maud Michelet; Anna Salvetti; David Durantel
Journal:  Cells       Date:  2020-10-14       Impact factor: 6.600

5.  Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro.

Authors:  Maud Michelet; Dulce Alfaiate; Brieux Chardès; Caroline Pons; Suzanne Faure-Dupuy; Thomas Engleitner; Rayan Farhat; Tobias Riedl; Anne-Flore Legrand; Roland Rad; Michel Rivoire; Fabien Zoulim; Mathias Heikenwälder; Anna Salvetti; David Durantel; Julie Lucifora
Journal:  JHEP Rep       Date:  2021-12-14

Review 6.  In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?

Authors:  Katja Giersch; Maura Dandri
Journal:  Viruses       Date:  2021-03-31       Impact factor: 5.048

Review 7.  Viral hepatitis update: Progress and perspectives.

Authors:  María B Pisano; Cecilia G Giadans; Diego M Flichman; Viviana E Ré; María V Preciado; Pamela Valva
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

Review 8.  Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.

Authors:  Stephan Urban; Christoph Neumann-Haefelin; Pietro Lampertico
Journal:  Gut       Date:  2021-06-08       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.